Childhood Acute Lymphoblastic Leukemia in Complete Remission Recruiting Phase 2 Trials for Fludarabine (DB01073)

IndicationStatusPhase
DBCOND0080800 (Childhood Acute Lymphoblastic Leukemia in Complete Remission)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01028716Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic MalignanciesTreatment
NCT00719888Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With Hematologic DiseaseTreatment